Eris Lifesciences Limited (BOM: 540596)

Market Cap	174.21B
Revenue (ttm)	24.85B
Net Income (ttm)	3.48B
Shares Out	n/a
EPS (ttm)	25.58
PE Ratio	49.99
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,630
Average Volume	3,774
Open	1,275.05
Previous Close	1,299.45
Day's Range	1,275.05 - 1,307.65
52-Week Range	810.10 - 1,593.00
Beta	n/a
RSI	38.75
Earnings Date	Jan 21, 2025

About Eris Lifesciences

Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India. The company offers various branded formulations in various therapeutic areas, such as anti–diabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women’s health, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram measureme...

• Industry: Pharmaceutical Preparations
• Founded: 2007
• Employees: 3,620
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540596

Financial Performance

In 2023, Eris Lifesciences's revenue was 19.91 billion, an increase of 19.83% compared to the previous year's 16.62 billion. Earnings were 3.92 billion, an increase of 2.57%.